TRUP compared with ABCL: revenue, margins and what each company keeps, and the suppliers and customers both name

TRUPTrupanion, Inc.

Mkt capRevenueRevenue

ABCLAbCellera Biologics Inc.

Mkt capRevenueRevenue

Compare

TRUPTrupanion, Inc.

ABCLAbCellera Biologics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TRUP

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±11.0%▲+5.85%×0.53

Q2 FY26±13.0%▲+15.46%×1.19

Q1 FY26±12.9%▲+1.42%×0.11

Feb 13 '26±11.4%▼−13.01%×1.14

ABCL1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.4%▲+10.30%×0.67

= impliedTRUP realized, solidABCL realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

TRUPTrupanion, Inc.

36.79▲+5.96%· post 36.03

Mkt cap$1.6BRevenue$406MQ3 FY26Revenue$1.4BFY25

ABCLAbCellera Biologics Inc.

11.90▲+6.87%· post 11.92

ClosedNov 6 '26

Mkt cap$3.6BRevenue$4MQ2 FY26Revenue$75MFY25

Compare

ClosedNov 6 '26

TRUPTrupanion, Inc.

ABCLAbCellera Biologics Inc.

36.79▲+5.96%post 36.03

Price

11.90▲+6.87%post 11.92

$1.6B

Mkt cap

$3.6B

Q3 FY26$406M

Revenue

$4MQ2 FY26

FY25$1.4B

Revenue

$75MFY25

TRUP36.79▲+5.96%vsABCL11.90▲+6.87%ClosedNov 6 '26